Paul Gregorevic

Paul Gregorevic

Auto-generated profile, based on publicly available information

Paul Gregorevic

Centre for Muscle Research, and Department of Anatomy and Physiology, The University of Melbourne, Parkville, Australia

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Cell Metabolism
Verified
Journal Article
Closed access
MWMartin Whitham
Martin Whitham
BPBenjamin L. Parker
Benjamin L. Parker
MFMartin Friedrichsen
Martin Friedrichsen
JHJanne R. Hingst
Janne R. Hingst
MHMarit Hjorth
Marit Hjorth
Mark A FebbraioMark A Febbraio
Mark A Febbraio

25 July 2004 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PGPaul Gregorevic
Paul Gregorevic
MBMichael J Blankinship
Michael J Blankinship
JAJames M Allen
James M Allen
RCRobert W Crawford
Robert W Crawford
LMLeonard Meuse
Leonard Meuse
JCJeffrey S Chamberlain
Jeffrey S Chamberlain

1 February 2012 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
BWBo Wang
Bo Wang
RKRadko Komers
Radko Komers
RCRosemarie Carew
Rosemarie Carew
CWCatherine E. Winbanks
Catherine E. Winbanks
BXBei Xu
Bei Xu
PKPhillip Kantharidis
Phillip Kantharidis
Synthesis and deposition of extracellular matrix (ECM) within the glomerulus and interstitium characterizes renal fibrosis, but the mechanisms underlying this process are incompletely understood. The profibrotic cytokine TGF-β1 modulates the expression of certain microRNAs (miRNAs), suggesting that miRNAs may have a role in the pathogenesis of renal fibrosis. Here, we exposed proximal tubular cells, primary mesangial cells, and podocytes to TGF-β1 to examine its effect on miRNAs and subsequent collagen synthesis. TGF-β1 reduced expression of the miR-29a/b/c/family, which targets collagen gene expression, and increased expression of ECM proteins. In both resting and TGF-β1–treated cells, ectopic expression of miR-29 repressed the expression of collagens I and IV at both the mRNA and protein levels by targeting the 3′untranslated region of these genes. Furthermore, we observed low levels of miR-29 in three models of renal fibrosis representing early and advanced stages of disease. Administration of the Rho-associated kinase inhibitor fasudil prevented renal fibrosis and restored expression of miR-29. Taken together, these data suggest that TGF-β1 inhibits expression of the miR-29 family, thereby promoting expression of ECM components. Pharmacologic modulation of these miRNAs may have therapeutic potential for progressive renal fibrosis.

15 September 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RMRichard J. Mills
Richard J. Mills
DTDrew M. Titmarsh
Drew M. Titmarsh
XKXaver König
Xaver König
BPBenjamin L. Parker
Benjamin L. Parker
JRJames G. Ryall
James G. Ryall
JHJames E. Hudson
James E. Hudson
Significance: Engineered cardiac muscle can be used to promote the structural and functional maturation of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs). However, previous studies have not yet produced cardiac tissues with metabolic and proliferative maturation. Here, we develop a 96-well screening platform and screen for cardiac maturation conditions in engineered cardiac muscle. We found that simulating the postnatal switch in metabolic substrates from carbohydrates to fatty acids promoted a switch in metabolism, DNA damage response, and cell cycle arrest in hPSC-CM. Our study shows that this mechanism can be harnessed to enhance the maturation of human hPSC-CM and cardiac tissues, which has major implications for stem cell sciences, drug discovery, and regenerative medicine.

9 October 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BBBianca C. Bernardo
Bianca C. Bernardo
XGXiao-Ming Gao
Xiao-Ming Gao
CWCatherine E. Winbanks
Catherine E. Winbanks
EBEsther J. H. Boey
Esther J. H. Boey
YTYow Keat Tham
Yow Keat Tham
JMJulie R. McMullen
Julie R. McMullen
MicroRNAs are dysregulated in a setting of heart disease and have emerged as promising therapeutic targets. MicroRNA-34 family members (miR-34a, -34b, and -34c) are up-regulated in the heart in response to stress. In this study, we assessed whether inhibition of the miR-34 family using an s.c.-delivered seed-targeting 8-mer locked nucleic acid (LNA)-modified antimiR (LNA-antimiR-34) can provide therapeutic benefit in mice with preexisting pathological cardiac remodeling and dysfunction due to myocardial infarction (MI) or pressure overload via transverse aortic constriction (TAC). An additional cohort of mice subjected to MI was given LNA-antimiR-34a (15-mer) to inhibit miR-34a alone as a comparison for LNA-antimiR-34. LNA-antimiR-34 (8-mer) efficiently silenced all three miR-34 family members in both cardiac stress models and attenuated cardiac remodeling and atrial enlargement. In contrast, inhibition of miR-34a alone with LNA-antimiR-34a (15-mer) provided no benefit in the MI model. In mice subjected to pressure overload, LNA-antimiR-34 improved systolic function and attenuated lung congestion, associated with reduced cardiac fibrosis, increased angiogenesis, increased Akt activity, decreased atrial natriuretic peptide gene expression, and maintenance of sarcoplasmic reticulum Ca 2+ ATPase gene expression. Improved outcome in LNA-antimiR-34–treated MI and TAC mice was accompanied by up-regulation of several direct miR-34 targets, including vascular endothelial growth factors, vinculin, protein O -fucosyltranferase 1, Notch1, and semaphorin 4B. Our results provide evidence that silencing of the entire miR-34 family can protect the heart against pathological cardiac remodeling and improve function. Furthermore, these data underscore the utility of seed-targeting 8-mer LNA-antimiRs in the development of new therapeutic approaches for pharmacologic inhibition of disease-implicated miRNA seed families.

2 July 2006 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PGPaul Gregorevic
Paul Gregorevic
JAJames M Allen
James M Allen
EMElina Minami
Elina Minami
MBMichael J Blankinship
Michael J Blankinship
MHMiki Haraguchi
Miki Haraguchi
JCJeffrey S Chamberlain
Jeffrey S Chamberlain